Zuellig acquisition marks big step into China for Cardinal Health
This article was originally published in Scrip
Executive Summary
Cardinal Health has acquired the leading Chinese healthcare distribution firm Zuellig Pharma China (ZPC) for $470 million, giving it a strong foothold in what is expected to become the second-largest pharma market worldwide within the next five years.